NCT04533568View on ClinicalTrials.gov

Ibuprofen in Migraine Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Migraine Without Aura
Interventions
DRUG

Ibuprofen 400 mg

400mg intravenous ibuprofen with 10mg intravenous metoclopramide Hcl in 100ml 0.9% NaCl for 30 minutes.

DRUG

Dexketoprofen

50 mg intravenous dexketoprofen with 10mg intravenous metoclopramide Hcl in 100ml 0.9% NaCl for 30 minutes.

Trial Locations (1)

06000

Kecioren Training and Research Hospital, Ankara

All Listed Sponsors
lead

Kecioren Education and Training Hospital

OTHER

NCT04533568 - Ibuprofen in Migraine Patients | Biotech Hunter | Biotech Hunter